humira solution
abbvie corporation - adalimumab - solution - 80mg - adalimumab 80mg - disease-modifying antirheumatic agents
humira solution
abbvie corporation - adalimumab - solution - 10mg - adalimumab 10mg - disease-modifying antirheumatic agents
humira solution
abbvie corporation - adalimumab - solution - 20mg - adalimumab 20mg - disease-modifying antirheumatic agents
hyrimoz solution
sandoz canada incorporated - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
hyrimoz solution
sandoz canada incorporated - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
idacio solution
fresenius kabi canada ltd - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
idacio solution
fresenius kabi canada ltd - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
idacio solution
fresenius kabi canada ltd - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents
hyrimoz solution
sandoz canada incorporated - adalimumab - solution - 20mg - adalimumab 20mg - disease-modifying antirheumatic agents
abrilada solution
pfizer canada ulc - adalimumab - solution - 40mg - adalimumab 40mg - disease-modifying antirheumatic agents